Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 7932

1.

Recurrent central catheter complications in a newborn: can we blame neonatal lupus?

Franco C, Fortunato F, Maria AT, Marçal M.

BMJ Case Rep. 2018 Feb 7;2018. pii: bcr-2017-223676. doi: 10.1136/bcr-2017-223676. No abstract available.

PMID:
29437715
2.

Subacute cutaneous lupus erythematosus presenting in twins.

Montuno MA, Church AA, Schoch JJ, Andrews ID.

Pediatr Dermatol. 2018 Feb 13. doi: 10.1111/pde.13434. [Epub ahead of print]

PMID:
29436018
3.

Drug-induced Rowell syndrome, a rare and difficult to manage disease: A case report.

Brănișteanu DE, Ianoşi SL, Dimitriu A, Stoleriu G, Oanţǎ A, Brănișteanu DC.

Exp Ther Med. 2018 Jan;15(1):785-788. doi: 10.3892/etm.2017.5557. Epub 2017 Nov 23.

4.

Cutaneous infiltration of plasmacytoid dendritic cells and t regulatory cells in skin lesions of polymorphic light eruption.

Rossi MT, Arisi M, Lonardi S, Lorenzi L, Ungari M, Serana F, Fusano M, Moggio E, Calzavara-Pinton PG, Venturini M.

J Eur Acad Dermatol Venereol. 2018 Feb 11. doi: 10.1111/jdv.14866. [Epub ahead of print]

PMID:
29430717
5.

Anti-tubulin-α-1C autoantibody in systemic lupus erythematosus: a novel indicator of disease activity and vasculitis manifestations.

Zhao X, Cheng Y, Gan Y, Jia R, Zhu L, Sun X.

Clin Rheumatol. 2018 Feb 9. doi: 10.1007/s10067-018-4024-3. [Epub ahead of print]

PMID:
29427009
6.

Ten-year retrospective clinicohistological study of cutaneous lupus erythematosus in Korea.

Oh EH, Kim EJ, Ro YS, Ko JY.

J Dermatol. 2018 Feb 9. doi: 10.1111/1346-8138.14233. [Epub ahead of print]

PMID:
29423919
7.

The role of regulatory T cells and genes involved in their differentiation in pathogenesis of selected inflammatory and neoplastic skin diseases. Part III: Polymorphisms of genes involved in Tregs' activation and function.

Nedoszytko B, Sokołowska-Wojdyło M, Renke J, Lange M, Trzonkowski P, Sobjanek M, Szczerkowska-Dobosz A, Niedoszytko M, Górska A, Romantowski J, Skokowski J, Kalinowski L, Nowicki RJ.

Postepy Dermatol Alergol. 2017 Dec;34(6):517-525. doi: 10.5114/pdia.2017.67053. Epub 2017 Dec 31. Review.

8.

The use of SLICC and ACR criteria to correctly label patients with cutaneous lupus and systemic lupus erythematosus.

Flynn A, Gilhooley E, O'Shea F, Wynne B.

Clin Rheumatol. 2018 Feb 1. doi: 10.1007/s10067-018-3999-0. [Epub ahead of print]

PMID:
29392510
9.

Synchronous presentation of systemic lupus erythematosus and oral reticular lichen planus.

Kiyani A, Shahroz N.

JAAD Case Rep. 2018 Jan 16;4(2):135-137. doi: 10.1016/j.jdcr.2017.08.008. eCollection 2018 Mar. No abstract available.

10.

Herpes zoster infection after topical steroid use in the setting of tumid lupus erythematosus.

Powell R, Hile G, Lowe L, Kahlenberg JM.

JAAD Case Rep. 2017 Dec 20;4(1):107-109. doi: 10.1016/j.jdcr.2017.09.005. eCollection 2018 Jan. No abstract available.

11.

Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, Lockshin MD, Sammaritano LR, Merrill JT, Porter TF, Sawitzke A, Lynch AM, Buyon JP, Salmon JE.

Ann Rheum Dis. 2018 Jan 25. pii: annrheumdis-2017-212224. doi: 10.1136/annrheumdis-2017-212224. [Epub ahead of print]

PMID:
29371202
12.

Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus.

Chalmers SA, Wen J, Doerner J, Stock A, Cuda CM, Makinde HM, Perlman H, Bosanac T, Webb D, Nabozny G, Fine JS, Klein E, Ramanujam M, Putterman C.

Arthritis Res Ther. 2018 Jan 25;20(1):10. doi: 10.1186/s13075-017-1500-0.

13.

Primary cutaneous anaplastic large-cell lymphoma: A case report.

Abed K, Stopa Z, Siewert-Gutowska M.

Medicine (Baltimore). 2018 Jan;97(4):e9645. doi: 10.1097/MD.0000000000009645.

14.

Cutaneous and systemic vasculitides in dermatology: a histological perspective.

Alberti-Violetti S, Berti E, Marzano AV.

G Ital Dermatol Venereol. 2018 Jan 24. doi: 10.23736/S0392-0488.18.05886-8. [Epub ahead of print]

PMID:
29368866
15.

Cutaneous lupus erythematosus: clinico-pathologic correlation.

Filotico R, Mastrandrea V.

G Ital Dermatol Venereol. 2018 Jan 24. doi: 10.23736/S0392-0488.18.05929-1. [Epub ahead of print]

PMID:
29368845
16.

Performance of the 2012 Systemic Lupus International Collaborating Clinics classification criteria versus the 1997 American College of Rheumatology classification criteria in adult and juvenile systemic lupus erythematosus. A systematic review and meta-analysis.

Hartman EAR, van Royen-Kerkhof A, Jacobs JWG, Welsing PMJ, Fritsch-Stork RDE.

Autoimmun Rev. 2018 Jan 31. pii: S1568-9972(18)30015-6. doi: 10.1016/j.autrev.2018.01.007. [Epub ahead of print] Review.

17.

[Renal Involvement in Connective Tissue Diseases].

Weiner SM.

Dtsch Med Wochenschr. 2018 Jan;143(2):89-100. doi: 10.1055/s-0043-106563. Epub 2018 Jan 22. German.

PMID:
29359289
18.

Matrix metalloproteinase-2 and -9 activity levels increase in cutaneous lupus erythematosus lesions and correlate with disease severity.

Ertugrul G, Keles D, Oktay G, Aktan S.

Arch Dermatol Res. 2018 Mar;310(2):173-179. doi: 10.1007/s00403-018-1811-2. Epub 2018 Jan 18.

PMID:
29349515
19.

Cutaneous hemophagocytosis: Clinicopathologic features of 21 cases.

Boggio F, Lora V, Cota C, Pereira A, Müllegger R, Prieto-Torres L, Cerroni L.

J Am Acad Dermatol. 2018 Feb;78(2):377-382. doi: 10.1016/j.jaad.2017.08.041.

PMID:
29332707
20.

Subacute cutaneous lupus erythematosus: is clopidogrel a trigger?

Hewitt C, Carton J, Wakelin S.

Clin Exp Dermatol. 2018 Jan 12. doi: 10.1111/ced.13379. [Epub ahead of print] No abstract available.

PMID:
29327459

Supplemental Content

Loading ...
Support Center